CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Executive or director change · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Other events
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- 4 Open-market buy Director bought 32,000 shares at an average $1.42 ($45,547)
- UPLOAD Other SEC-generated Letter
- 4 Open-market buy Director bought 86,000 shares at an average $1.43 ($123,240)
- 4 Open-market buy Director bought 32,000 shares at an average $1.47 ($47,000)
- 4 Open-market buy 10% owner bought 34,903 shares at an average $1.51 ($52,700)
- 4 Open-market buy Director bought 311,481 shares at an average $1.48 ($460,443)
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
Page 20 of 50 · 996 filings